Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Methodological approaches to evaluate the impact of FDA drug safety communications.

Kesselheim AS, Campbell EG, Schneeweiss S, Rausch P, Lappin BM, Zhou EH, Seeger JD, Brownstein JS, Woloshin S, Schwartz LM, Toomey T, Dal Pan GJ, Avorn J.

Drug Saf. 2015 Jun;38(6):565-75. doi: 10.1007/s40264-015-0291-y.

PMID:
25968811
2.

Attitudes about low-dose computed tomography screening for lung cancer: a survey of American Thoracic Society Clinicians.

Simmons J, Gould MK, Woloshin S, Schwartz LM, Wiener RS.

Am J Respir Crit Care Med. 2015 Feb 15;191(4):483-6. doi: 10.1164/rccm.201409-1747LE. No abstract available.

PMID:
25679109
3.

US Food and Drug Administration and design of drug approval studies.

Woloshin S, Schwartz LM, Frankel B, Faerber A.

JAMA. 2014 Nov 26;312(20):2163-5. doi: 10.1001/jama.2014.13329. No abstract available.

PMID:
25423223
4.

Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death.

Howlader N, Mariotto AB, Woloshin S, Schwartz LM.

J Natl Cancer Inst Monogr. 2014 Nov;2014(49):255-64. doi: 10.1093/jncimonographs/lgu022.

PMID:
25417239
5.

When do changes in cancer survival mean progress? The insight from population incidence and mortality.

Cho H, Mariotto AB, Schwartz LM, Luo J, Woloshin S.

J Natl Cancer Inst Monogr. 2014 Nov;2014(49):187-97. doi: 10.1093/jncimonographs/lgu014.

PMID:
25417232
6.

Cancer survival: an overview of measures, uses, and interpretation.

Mariotto AB, Noone AM, Howlader N, Cho H, Keel GE, Garshell J, Woloshin S, Schwartz LM.

J Natl Cancer Inst Monogr. 2014 Nov;2014(49):145-86. doi: 10.1093/jncimonographs/lgu024.

PMID:
25417231
7.

Drug treatment of obesity--reply.

Schwartz LM, Woloshin S.

JAMA Intern Med. 2014 Aug;174(8):1415-6. doi: 10.1001/jamainternmed.2014.1635. No abstract available.

PMID:
25090180
8.

Overdiagnosis: how cancer screening can turn indolent pathology into illness.

Brodersen J, Schwartz LM, Woloshin S.

APMIS. 2014 Aug;122(8):683-9. doi: 10.1111/apm.12278. Epub 2014 May 26. Review.

PMID:
24862511
9.

Resource use and guideline concordance in evaluation of pulmonary nodules for cancer: too much and too little care.

Wiener RS, Gould MK, Slatore CG, Fincke BG, Schwartz LM, Woloshin S.

JAMA Intern Med. 2014 Jun;174(6):871-80. doi: 10.1001/jamainternmed.2014.561.

10.

The new weight-loss drugs, lorcaserin and phentermine-topiramate: slim pickings?

Woloshin S, Schwartz LM.

JAMA Intern Med. 2014 Apr;174(4):615-9. doi: 10.1001/jamainternmed.2013.14629.

PMID:
24515599
11.

Promotion of "low T" and the role of testosterone clinical trials--reply.

Schwartz LM, Woloshin S.

JAMA Intern Med. 2014 Feb 1;174(2):306-7. doi: 10.1001/jamainternmed.2013.12733. No abstract available.

PMID:
24493615
12.

Using radiology reports to encourage evidence-based practice in the evaluation of small, incidentally detected pulmonary nodules. A preliminary study.

Woloshin S, Schwartz LM, Dann E, Black WC.

Ann Am Thorac Soc. 2014 Feb;11(2):211-4. doi: 10.1513/AnnalsATS.201307-242BC.

PMID:
24354970
13.

Medical communication companies and continuing medical education: clouding the sunshine?

Schwartz LM, Woloshin S.

JAMA. 2013 Dec 18;310(23):2507-8. doi: 10.1001/jama.2013.281640. No abstract available. Erratum in: JAMA. 2014 Apr 23-30;311(16):1694.

PMID:
24346987
14.

Authors' reply to Quantrill, Benger, Ripley and colleagues, Roach, Rogers, and Haldar and colleagues.

Wiener RS, Schwartz LM, Woloshin S.

BMJ. 2013 Aug 20;347:f5131. doi: 10.1136/bmj.f5131. No abstract available.

PMID:
23963558
15.

The Drug Facts Box: Improving the communication of prescription drug information.

Schwartz LM, Woloshin S.

Proc Natl Acad Sci U S A. 2013 Aug 20;110 Suppl 3:14069-74. doi: 10.1073/pnas.1214646110. Epub 2013 Aug 13.

16.

Low "T" as in "template": how to sell disease.

Schwartz LM, Woloshin S.

JAMA Intern Med. 2013 Aug 12;173(15):1460-2. doi: 10.1001/jamainternmed.2013.7579. No abstract available.

PMID:
23939516
17.

Accountable prescribing.

Morden NE, Schwartz LM, Fisher ES, Woloshin S.

N Engl J Med. 2013 Jul 25;369(4):299-302. doi: 10.1056/NEJMp1301805. No abstract available.

18.

When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found.

Wiener RS, Schwartz LM, Woloshin S.

BMJ. 2013 Jul 2;347:f3368. doi: 10.1136/bmj.f3368. No abstract available.

PMID:
23820021
19.

Know Your Chances: Understanding Health Statistics.

Woloshin S, Schwartz LM, Welch HG.

Berkeley (CA): University of California Press; 2008.

20.

Winding back the harms of too much medicine.

Moynihan R, Glasziou P, Woloshin S, Schwartz L, Santa J, Godlee F.

BMJ. 2013 Feb 26;346:f1271. doi: 10.1136/bmj.f1271. No abstract available.

PMID:
23444422
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk